The latest price target for NOVONIX (NASDAQ:NVX) was reported by Chardan Capital on May 30, 2024. The analyst firm set a price target for $4.00 expecting NVX to rise to within 12 months (a possible 142.42% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for NOVONIX (NASDAQ:NVX) was provided by Chardan Capital, and NOVONIX initiated their buy rating.

There is no last upgrade for NOVONIX

There is no last downgrade for NOVONIX.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NOVONIX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NOVONIX was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.

While ratings are subjective and will change, the latest NOVONIX (NVX) rating was a initiated with a price target of $0.00 to $4.00. The current price NOVONIX (NVX) is trading at is $1.65, which is within the analyst’s predicted range.